Invesco Pharmaceuticals ETF $PJP Shares Sold by Harbour Investments Inc.

Harbour Investments Inc. lessened its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 56.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 429 shares of the company’s stock after selling 550 shares during the period. Harbour Investments Inc.’s holdings in Invesco Pharmaceuticals ETF were worth $34,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Cetera Investment Advisers boosted its stake in Invesco Pharmaceuticals ETF by 12.7% in the first quarter. Cetera Investment Advisers now owns 6,240 shares of the company’s stock valued at $541,000 after acquiring an additional 702 shares in the last quarter. LPL Financial LLC boosted its stake in Invesco Pharmaceuticals ETF by 0.5% in the first quarter. LPL Financial LLC now owns 49,139 shares of the company’s stock valued at $4,256,000 after acquiring an additional 244 shares in the last quarter. Joseph Group Capital Management boosted its stake in Invesco Pharmaceuticals ETF by 11.1% in the first quarter. Joseph Group Capital Management now owns 19,335 shares of the company’s stock valued at $1,675,000 after acquiring an additional 1,938 shares in the last quarter. N.E.W. Advisory Services LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF in the first quarter valued at about $75,000. Finally, Federation des caisses Desjardins du Quebec raised its holdings in shares of Invesco Pharmaceuticals ETF by 6.3% in the first quarter. Federation des caisses Desjardins du Quebec now owns 27,892 shares of the company’s stock valued at $2,416,000 after buying an additional 1,645 shares during the last quarter.

Invesco Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:PJP opened at $95.03 on Friday. The company has a 50-day simple moving average of $92.60 and a 200-day simple moving average of $85.02. Invesco Pharmaceuticals ETF has a one year low of $72.25 and a one year high of $96.00. The stock has a market capitalization of $271.79 million, a price-to-earnings ratio of 15.59 and a beta of 0.66.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.